Graham Peter Lidgard insider trades: Exact Sciences (EXAS) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Graham reports to the SEC
Open-market buys and sales
37 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Mar 11, 2021 | EXAS | ↓ Sell10b5-1 | 43,241 | $130.00 | $5.6M | Direct | Mar 15, 2021 (4d) |
| Mar 5, 2021 | EXAS | ↓ Sell10b5-1 | 11,735 | $121.33 | $1.4M | Direct | Mar 8, 2021 (3d) |
| Mar 2, 2021 | EXAS | ↓ Sell10b5-1 | 2,524 | $138.42 | $349K | Direct | Mar 3, 2021 (1d) |
| Mar 1, 2021 | EXAS | ↓ Sell10b5-1 | 1,603 | $137.44 | $220K | Direct | Mar 2, 2021 (1d) |
| Feb 24, 2021 | EXAS | ↓ Sell10b5-1 | 5,842 | $136.30 | $796K | Direct | Feb 25, 2021 (1d) |
| Feb 17, 2021 | EXAS | ↓ Sell10b5-1 | 2,131 | $142.66 | $304K | Direct | Feb 18, 2021 (1d) |
| Nov 7, 2018 | EXAS | ↓ Sell10b5-1 | 38,311 | $75.01 | $2.9M | Direct | Nov 7, 2018 (0d) |
| Nov 1, 2018 | EXAS | ↓ Sell10b5-1 | 79,673 | $71.73 | $5.7M | Direct | Nov 2, 2018 (1d) |
| Oct 8, 2018 | EXAS | ↓ Sell10b5-1 | 58,000 | $69.36 | $4.0M | Direct | Oct 10, 2018 (2d) |
| Mar 13, 2018 | EXAS | ↓ Sell10b5-1 | 14,550 | $51.98 | $756K | Direct | Mar 13, 2018 (0d) |
| Feb 27, 2018 | EXAS | ↓ Sell10b5-1 | 35,025 | $42.88 | $1.5M | Direct | Feb 28, 2018 (1d) |
| Feb 26, 2018 | EXAS | ↓ Sell10b5-1 | 27,428 | $40.44 | $1.1M | Direct | Feb 27, 2018 (1d) |
| Dec 1, 2017 | EXAS | ↓ Sell10b5-1 | 45,770 | $58.27 | $2.7M | Direct | Dec 4, 2017 (3d) |
| Nov 1, 2017 | EXAS | ↓ Sell10b5-1 | 45,775 | $53.60 | $2.5M | Direct | Nov 3, 2017 (2d) |
| Oct 2, 2017 | EXAS | ↓ Sell10b5-1 | 81,025 | $47.16 | $3.8M | Direct | Oct 3, 2017 (1d) |
| Sep 5, 2017 | EXAS | ↓ Sell10b5-1 | 75,683 | $40.81 | $3.1M | Direct | Sep 7, 2017 (2d) |
| Sep 1, 2017 | EXAS | ↓ Sell10b5-1 | 45,775 | $41.49 | $1.9M | Direct | Sep 5, 2017 (4d) |
| Mar 13, 2017 | EXAS | ↓ Sell10b5-1 | 2,945 | $21.16 | $62K | Direct | Mar 14, 2017 (1d) |
| Feb 27, 2017 | EXAS | ↓ Sell10b5-1 | 8,668 | $21.51 | $186K | Direct | Feb 28, 2017 (1d) |
| Nov 15, 2016 | EXAS | ↓ Sell | 311,112 | $17.46 | $5.4M | Direct | Nov 15, 2016 (0d) |
| Jul 26, 2016 | EXAS | ↓ Sell10b5-1 | 7,383 | $14.82 | $109K | Direct | Jul 27, 2016 (1d) |
| Mar 10, 2016 | EXAS | ↓ Sell10b5-1 | 3,041 | $6.05 | $18K | Direct | Mar 11, 2016 (1d) |
| Feb 25, 2016 | EXAS | ↓ Sell10b5-1 | 2,997 | $5.52 | $17K | Direct | Feb 26, 2016 (1d) |
| Feb 23, 2016 | EXAS | ↓ Sell10b5-1 | 2,411 | $6.39 | $15K | Direct | Feb 24, 2016 (1d) |
| Jan 4, 2016 | EXAS | ↓ Sell10b5-1 | 3,463 | $8.72 | $30K | Direct | Jan 5, 2016 (1d) |
| Jul 27, 2015 | EXAS | ↓ Sell10b5-1 | 12,579 | $24.04 | $302K | Direct | Jul 28, 2015 (1d) |
| Feb 26, 2015 | EXAS | ↓ Sell10b5-1 | 3,938 | $23.44 | $92K | Direct | Feb 26, 2015 (0d) |
| Feb 24, 2015 | EXAS | ↓ Sell10b5-1 | 4,037 | $22.90 | $92K | Direct | Feb 25, 2015 (1d) |
| Jan 2, 2015 | EXAS | ↓ Sell10b5-1 | 3,363 | $26.72 | $90K | Direct | Jan 5, 2015 (3d) |
| Oct 29, 2014 | EXAS | ↓ Sell10b5-1 | 8,015 | $24.68 | $198K | Direct | Oct 29, 2014 (0d) |
| Oct 20, 2014 | EXAS | ↓ Sell | 150,000 | $23.49 | $3.5M | Direct | Oct 20, 2014 (0d) |
| Jul 25, 2014 | EXAS | ↓ Sell10b5-1 | 11,081 | $15.99 | $177K | Direct | Jul 29, 2014 (4d) |
| Feb 24, 2014 | EXAS | ↓ Sell10b5-1 | 3,160 | $14.07 | $44K | Direct | Feb 25, 2014 (1d) |
| Jan 2, 2014 | EXAS | ↓ Sell10b5-1 | 10,288 | $11.96 | $123K | Direct | Jan 3, 2014 (1d) |
| Oct 28, 2013 | EXAS | ↓ Sell10b5-1 | 7,430 | $11.07 | $82K | Direct | Oct 30, 2013 (2d) |
| Dec 31, 2008 | NGEN | ↑ Buy | 1,666 | $0.12 | $198 | Direct | Jan 21, 2009 (21d) |
| Jun 30, 2008 | NGEN | ↑ Buy | 1,666 | $0.31 | $510 | Direct | Jul 3, 2008 (3d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other EXAS insiders
Open-market trades in the last 12 months
About Graham Peter Lidgard's insider trades
Graham Peter Lidgard is Chief Science Officer at Exact Sciences (EXAS). Since Jun 30, 2008, Graham has reported 2 open-market purchases worth $708 and 35 sales worth $49.2M on SEC Form 4. There have been no open-market trades in the last 12 months.
33 sales (82% of the value sold) were made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so they say little about how the insider sees the stock today.
Their filings also include option exercises (32 filings), grants and awards (26 filings), shares withheld for taxes (7 filings), gifts (4 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every EXAS insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.